Background—Blocking of glycoprotein VI– dependent pathways by interfering in vascular collagen sites is commonly seen as an attractive target for an antiplatelet therapy of acute atherosclerotic diseases such as myocardial infarction or stroke. Revacept (soluble dimeric glycoprotein VI-Fc fusion protein) has been shown to reduce platelet adhesion by blocking vascular collagen in plaques or eros...

Background and Purpose Platelet aggregation plays an important role in the pathogenesis of thromboembolic cerebrovascular disease. Leukocytes can efficiently stimulate as well as inhibit platelet aggregability. We studied the influence of leukocytes on collagen-induced platelet aggregation in patients with acute ischemic stroke. Methods We investigated 23 patients within 2 days after stroke and...

BACKGROUND Mild hypothermia is currently standard of care for cardiac arrest patients in many hospitals and a common belief is that hypothermia attenuates platelet aggregation. We wanted to examine the effects of clopidogrel on platelet aggregation during hypothermia. METHODS Platelet reactivity at 37° C and 33° C was evaluated by light transmission aggregometry and vasodilator-stimulated pho...

Kami-shoyo-san (Jia-Wei-Xiao-Yao-San), Toki-shakuyaku-san (Dang-Gui-Shao-Yao-San) and Toki-shigyaku-ka-goshuyu-shokyo-to (Dang-Gui-Si-Ni-Jia-Wu-Zhu-Yu-Sheng-Jiang-Tang) are Kampo (traditional Chinese) medicines which are traditionally and effectively used for the treatment of chilly sensation (Hiesho) in Japan, but the active components and their detailed mechanisms have not yet been clarified....

Platelet-type von Willebrand disease (vWD) and pseudo-vWD are two recently described intrinsic platelet defects characterized by enhanced ristocetin-induced agglutination in platelet-rich plasma. A similar finding is also typical of type IIB vWD, where it has been related to a von Willebrand factor (vWF) rather than a platelet abnormality. Platelet aggregation induced by unmodified human vWF in...

Light transmission platelet aggregation tests are important for diagnosing platelet function defects. However, uncertainties exist about the best procedures to determine aggregation reference intervals. We investigated methods for determining reference intervals for light transmission aggregation tests, using the % maximal aggregation values for prospectively collected data on healthy control s...

This work has been the winner of the “Dr. Pedro Cossio Foundation 2011” Award MTSAC Full Member of the Argentine Society of Cardiology 1 Departament of Cardiology and Cardiovascular Surgery, FLENI 2 Mount Sinai School of Medicine, New York, USA RESOURCES AND SUPPORT: Self-founded. HERNÁN COHEN ARAZI , MARIANA CARNEVALINI, ESTELA FALCONI, RODRIGO OVEJERO, MARIANO GIORGI , CHRISTIAN CAROLI , CARL...

The digestion of fibrinogen with various concentrations of trypsin results in the formation of a variety of degradation products. Degradation products formed in this way have been purified by DEAE cellulose column chromatography and their effects on platelet aggregation investigated.TWO METHODS HAVE BEEN USED TO STUDY PLATELET AGGREGATION: a turbidimetric method which assesses platelet aggregat...

OBJECTIVE Adenosine signaling is known to inhibit platelet aggregation. Extracellular adenosine mainly stems from enzymatic phosphohydrolysis of precursor nucleotides via ecto-5'-nucleotidase. Previous studies suggest that soluble 5'-nucleotidase (5'-NT) derived from Crotalus atrox venom may be clinically beneficial in vascular leakage, myocardial, renal, and intestinal ischemia, or acute lung ...

We would like to suggest another factor, namely, that of decreased platelet aggregation, which may contribute to their observation. We studied platelet aggregation in 25 newly diagnosed patients with Parkinson's disease and 25 ageand sex-matched controls. None were diabetic, hypertensive, smokers, or on any treatment. Citrated blood was collected by venipuncture and centrifuged at 20Qg for 10 m...